A Phase 3 Pilot Study to Describe the Pharmacokinetics of Tacrolimus in Patients Undergoing Primary Liver Donor Liver Transplantation Treated With Prograf Injection and Modified Release Tacrolimus Based Immunosuppressive Regimen.
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2010
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 20 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Mar 2010 Actual patient number (10) added as reported by ClinicalTrials.gov.